Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Detalles Bibliográficos
Autores principales: Bedognetti, Davide, Wang, Ena, Marincola, Francesco M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203509/
https://www.ncbi.nlm.nih.gov/pubmed/25340012
http://dx.doi.org/10.4161/onci.28727
_version_ 1782340404834729984
author Bedognetti, Davide
Wang, Ena
Marincola, Francesco M
author_facet Bedognetti, Davide
Wang, Ena
Marincola, Francesco M
author_sort Bedognetti, Davide
collection PubMed
description
format Online
Article
Text
id pubmed-4203509
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-42035092014-10-22 Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome Bedognetti, Davide Wang, Ena Marincola, Francesco M Oncoimmunology Editorial Landes Bioscience 2014-04-09 /pmc/articles/PMC4203509/ /pubmed/25340012 http://dx.doi.org/10.4161/onci.28727 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Editorial
Bedognetti, Davide
Wang, Ena
Marincola, Francesco M
Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
title Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
title_full Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
title_fullStr Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
title_full_unstemmed Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
title_short Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
title_sort meta-analysis and metagenes: cxcl-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203509/
https://www.ncbi.nlm.nih.gov/pubmed/25340012
http://dx.doi.org/10.4161/onci.28727
work_keys_str_mv AT bedognettidavide metaanalysisandmetagenescxcl13drivensignatureasarobustmarkerofintratumoralimmuneresponseandpredictorofbreastcancerchemotherapeuticoutcome
AT wangena metaanalysisandmetagenescxcl13drivensignatureasarobustmarkerofintratumoralimmuneresponseandpredictorofbreastcancerchemotherapeuticoutcome
AT marincolafrancescom metaanalysisandmetagenescxcl13drivensignatureasarobustmarkerofintratumoralimmuneresponseandpredictorofbreastcancerchemotherapeuticoutcome

Ejemplares similares